Microbix Biosystems Inc. (MBXBF)
OTCMKTS
· Delayed Price · Currency is USD
0.2600
+0.0001 (0.04%)
May 14, 2025, 11:19 AM EDT
Microbix Biosystems Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| Revenue | 23.03 | 25.39 | 16.51 | 19.08 | 18.59 | 10.52 | Upgrade
|
| Revenue Growth (YoY) | 2.72% | 53.77% | -13.43% | 2.60% | 76.66% | -21.53% | Upgrade
|
| Cost of Revenue | 10.11 | 10 | 9.03 | 7.95 | 7.55 | 5.86 | Upgrade
|
| Gross Profit | 12.92 | 15.39 | 7.48 | 11.12 | 11.04 | 4.66 | Upgrade
|
| Selling, General & Admin | 8.38 | 9.36 | 8.17 | 6.72 | 5.17 | 4.17 | Upgrade
|
| Research & Development | 2.24 | 2.13 | 2.05 | 1.8 | 1.03 | 1.01 | Upgrade
|
| Operating Expenses | 10.62 | 11.49 | 10.22 | 8.51 | 6.21 | 5.19 | Upgrade
|
| Operating Income | 2.31 | 3.91 | -2.74 | 2.61 | 4.84 | -0.52 | Upgrade
|
| Interest Expense | -0.92 | -0.92 | -0.84 | -0.83 | -1.6 | -1.06 | Upgrade
|
| Interest & Investment Income | 0.69 | 0.69 | 0.46 | 0.08 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 2.07 | 3.67 | -3.12 | 1.87 | 3.23 | -1.58 | Upgrade
|
| Asset Writedown | - | - | 3.08 | - | - | -3.08 | Upgrade
|
| Pretax Income | 2.07 | 3.67 | -0.04 | 1.87 | 3.23 | -4.66 | Upgrade
|
| Income Tax Expense | 0.15 | 0.15 | - | 0.08 | - | 1.57 | Upgrade
|
| Net Income | 1.92 | 3.52 | -0.04 | 1.79 | 3.23 | -6.23 | Upgrade
|
| Net Income to Common | 1.92 | 3.52 | -0.04 | 1.79 | 3.23 | -6.23 | Upgrade
|
| Net Income Growth | -48.27% | - | - | -44.68% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 136 | 137 | 138 | 135 | 115 | 105 | Upgrade
|
| Shares Outstanding (Diluted) | 137 | 137 | 138 | 142 | 142 | 105 | Upgrade
|
| Shares Change (YoY) | -0.43% | -0.30% | -2.67% | 0.00% | 35.14% | 7.99% | Upgrade
|
| EPS (Basic) | 0.01 | 0.03 | -0.00 | 0.01 | 0.03 | -0.06 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.03 | -0.00 | 0.01 | 0.03 | -0.06 | Upgrade
|
| EPS Growth | -47.75% | - | - | -49.98% | - | - | Upgrade
|
| Free Cash Flow | 2 | 2.71 | -2.11 | 1.44 | 0.86 | -0.8 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.02 | -0.01 | 0.01 | 0.01 | -0.01 | Upgrade
|
| Gross Margin | 56.11% | 60.61% | 45.30% | 58.32% | 59.40% | 44.28% | Upgrade
|
| Operating Margin | 10.01% | 15.38% | -16.57% | 13.68% | 26.01% | -4.98% | Upgrade
|
| Profit Margin | 8.34% | 13.86% | -0.24% | 9.38% | 17.39% | -59.17% | Upgrade
|
| Free Cash Flow Margin | 8.68% | 10.68% | -12.78% | 7.55% | 4.65% | -7.64% | Upgrade
|
| EBITDA | 3.58 | 5.2 | -1.9 | 3.33 | 5.39 | -0.1 | Upgrade
|
| EBITDA Margin | 15.53% | 20.49% | -11.48% | 17.45% | 28.97% | -0.91% | Upgrade
|
| D&A For EBITDA | 1.27 | 1.3 | 0.84 | 0.72 | 0.55 | 0.43 | Upgrade
|
| EBIT | 2.31 | 3.91 | -2.74 | 2.61 | 4.84 | -0.52 | Upgrade
|
| EBIT Margin | 10.01% | 15.38% | -16.57% | 13.68% | 26.01% | -4.98% | Upgrade
|
| Effective Tax Rate | 7.27% | 4.10% | - | 4.14% | - | - | Upgrade
|
| Revenue as Reported | 23.03 | 25.39 | 16.51 | 19.08 | 18.59 | 10.52 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.